Crossmark

Exosomes derived from mesenchymal stem cells curbs the progression of clear cell renal cell carcinoma through T-cell immune response

Published Online: 2021-06-07

Published Print: 2021-08

Authors

Li, Daoyuan

Lin, Feifei

Li, Guoping

Zeng, Fanchang https://orcid.org/0000-0002-2010-8495
Funding

Funding for this research was provided by:

Scientific Research Projects of Health Industry in Hainan Province (20A200030)
License Information

Text and Data Mining valid from 2021-06-07

Version of Record valid from 2021-06-07
More Information

Article History

Received: 20 January 2021

Accepted: 1 June 2021

First Online: 7 June 2021

Declarations

:

: The authors declare that they have no competing interests.

Document is current